Emami Reports 15% Growth in Revenue as Domestic Business Delivers Strong Performance

Emami Reports 15% Growth in Revenue as Domestic Business Delivers Strong Performance​

Emami Limited announced its unaudited financial results for the first quarter of FY27, noting a resilient 15% growth in consolidated revenue from operations despite challenging operating conditions characterized by geopolitical unrest and elevated input costs. The company reported an EBITDA of ₹226 crore and Profit Before Tax (PBT) of ₹194.7 crore.

The results reflected the strength of Emami’s diversified portfolio and strategic execution, although the International Business faced headwinds due to disruptions stemming from the West Asia conflict.

On a consolidated basis, Revenue from Operations grew by 15% to ₹1,039.2 crore in Q1FY27, compared to Q1FY26. The company maintained disciplined cost management and operational efficiencies, resulting in an EBITDA growth of 6%.

Domestic Business and Segment Performance​

The domestic business showed robust momentum, with reported revenues growing by 20%. On a like-to-like basis, the domestic segment grew by 12%, accompanied by an 8% volume growth.

The Strategic Investments portfolio emerged as a standout performer, showing impressive growth of 61% on a like-to-like basis and now contributing approximately 18% to the domestic business. The company’s channel transformation continued its upward trajectory; organized channels grew by 19% (like-to-like) and contribute 32% of the domestic business.

Performance across core categories included:

• Hair & Scalp Care: This category delivered 11% growth.
• Skin Care: Growth was reported at 3%.
• Health Care: Health Care grew by 2%.

The International Business saw a decline of 12%, primarily attributed to disruptions from the West Asia conflict, which limited order execution capacity. Despite this, the company noted that fundamental international franchise strength remains intact.

Profitability and Financial Overview​

While gross margins contracted by 360 basis points to 65.8% due to heightened input costs—driven by crude oil prices and inflation in packaging materials and other key inputs—the company managed disciplined cost control, leading to PBT growing by 4% to ₹194.7 crore (Q1FY27).

The following table details the Q1FY27 consolidated financial performance:

Management Perspective​

Harsha V Agarwal, Vice Chairman and Managing Director of Emami Limited, highlighted the strong performance achieved despite a challenging environment marked by geopolitical disruptions and inflation. He expressed particular encouragement over the growing contribution of the Strategic Investments portfolio, which now constitutes nearly 18% of domestic business, reinforcing the strategy to build multiple growth engines alongside core brands.

Mohan Goenka, Vice Chairman and Whole-Time Director, noted that the quarter tested the operating model due to input cost pressures. However, focused execution and cost optimization facilitated EBITDA growth of 6%, enabling the company to remain well positioned to strengthen profitability as input costs begin to ease.

Strategic Investments Detail​

The strategic investments portfolio includes Axiom Ayurveda (AloFrut), which has become a wholly owned subsidiary, and IncNut, where Emami acquired a majority stake through Vedix and SkinKraft, enhancing presence in the personalised beauty and personal care segment.

***
Note: Financial figures are presented exactly as per company data.

EMAMILTD Stock Price Movement​

As of 2:35 PM, shares of Emami Limited are rocketing to ₹439, gaining 8.13% as the stock rallies aggressively in live trading. This powerful ascent sees the equity hit its 52-week high, with current traded volume standing at 98,561 shares.